Medulloblastoma is the most common malignant brain tumor of childhood. In the US, there is an average annual incidence rate of 0.41 per 100,000 in children ages ≤19 years.[5]Ostrom QT, Price M, Ryan K, et al. CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2022 Sep 6;24(suppl 3):iii1-38.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9447434
http://www.ncbi.nlm.nih.gov/pubmed/36066969?tool=bestpractice.com
The age of diagnosis is highest in the 1-4 and 5-9 age groups, with an annual average incidence rate of 0.59 per 100,000 and 0.63 per 100,000 respectively. The average annual incidence rate then declines in the 10-14 age group (0.33 per 100,000) and 15-19 age group (0.16 per 100,000).[5]Ostrom QT, Price M, Ryan K, et al. CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2022 Sep 6;24(suppl 3):iii1-38.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9447434
http://www.ncbi.nlm.nih.gov/pubmed/36066969?tool=bestpractice.com
Overall incidence appears to have remained stable over the years.[6]Partap S, Curran EK, Propp JM, et al. Medulloblastoma incidence has not changed over time: a CBTRUS study. J Pediatr Hematol Oncol. 2009 Dec;31(12):970-1.
http://www.ncbi.nlm.nih.gov/pubmed/19887963?tool=bestpractice.com
[7]Khanna V, Achey RL, Ostrom QT, et al. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. J Neurooncol. 2017 Dec;135(3):433-41.
http://www.ncbi.nlm.nih.gov/pubmed/28828582?tool=bestpractice.com
Between 2001 and 2010 in Great Britain (England, Scotland, and Wales), there were 4166 registered central nervous system tumors among children <15 years. Embryonal tumors made up 17% of these, of which 73% were medulloblastoma.[8]Stiller CA, Bayne AM, Chakrabarty A, et al. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study. BMC Cancer. 2019 Feb 11;19(1):139.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6371471
http://www.ncbi.nlm.nih.gov/pubmed/30744596?tool=bestpractice.com
There is a slight male predominance; incidence in Great Britain among males has been reported at 0.51 per 100,000 and 0.30 per 100,000 for females.[5]Ostrom QT, Price M, Ryan K, et al. CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2022 Sep 6;24(suppl 3):iii1-38.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9447434
http://www.ncbi.nlm.nih.gov/pubmed/36066969?tool=bestpractice.com
There are a few reports of familial medulloblastomas in monozygotic twins.[9]Chidambaram B, Santhosh V, Shankar SK. Identical twins with medulloblastoma occurring in infancy. Childs Nerv Syst. 1998 Sep;14(9):421-5.
http://www.ncbi.nlm.nih.gov/pubmed/9808250?tool=bestpractice.com
[10]Scheurlen W, Sörensen N, Roggendorf W, et al. Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins. Eur J Pediatr. 1996 Oct;155(10):880-4.
http://www.ncbi.nlm.nih.gov/pubmed/8891558?tool=bestpractice.com
Medulloblastomas have a marked propensity to seed within the cerebrospinal fluid pathways, with evidence of such metastatic spread occurring in between 11% and 43% of cases at diagnosis.[11]Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995 Sep;25(3):166-78.
http://www.ncbi.nlm.nih.gov/pubmed/7623725?tool=bestpractice.com
[12]Allen JC, Epstein F. Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis. J Neurosurg. 1982 Oct;57(4):446-51.
http://www.ncbi.nlm.nih.gov/pubmed/7108593?tool=bestpractice.com